| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
| The biotechnology area is currently witnessing significant advancements, particularly in innovative technologies like CRISPR and gene therapies. The focus on cancer treatments and strong funding news indicates a vibrant environment conducive to growth. Companies are actively involved in drug development and pursuing FDA applications, reflecting the sector's potential. Overall, positive sentiment around new treatments is enhancing investor optimism. The price action of Small Biotechnology (XBI) sector is shaped by numerous forces, ranging from broad macroeconomic trends to company-specific performance and market structure. The trend sentiment at 0.6 is bullish. The market sentiment at -0.6 is bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for XBI since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for Small Biotechnology sector is at 0.3, and the negative at -0.8 on 2026-06-01. The forces of Market Risk Appetite (-2), Option Sentiment (-1.5), Sentiment towards Fundamentals (-1), and Valuation Sentiment (-0.5) will drive down the price. The forces of Price Level Sentiment (0), Sector Price Trend (0.6), and Broad Market Trend (0.9) will drive up the price. The sentiment for Broad Market Trend is calculated based on SPY trend. The sentiment for Sector Price Trend is calculated based on XBI trend. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Prefrence is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice Sector Rotation Notification
| XBI | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | 1%(0.4%) | 133.62 | 1.99% | 51 | -2.32% | 0.23% | 0.6 | -0.3 | 1% | -0.6 | Wait | 50% | -1 | 3.8 |
| 2026-05-31 | 0%(0.3%) | 1 | -0.3 | -1 | -0.5 | |||||||||
| 2026-05-30 | 0%(0.3%) | 1 | -0.3 | -1 | -0.5 | |||||||||
| 2026-05-29 | 1%(0.3%) | 136.79 | 2% | 82 | 0.61% | 0.15% | 1 | 0.2 | 0.7% | -0.6 | Long | 55% | -1 | 3.5 |
| 2026-05-28 | 0%(0.1%) | 135.96 | 1.95% | 78 | 1.1% | 0% | 0.9 | 0.2 | 0.8% | -0.6 | Long | 55% | -1 | 7.5 |
| 2026-05-27 | 0%(0.1%) | 134.48 | 2.02% | 66 | 0.82% | 0% | 1.3 | -0 | 0.9% | -0.6 | Long | 55% | -1 | 7.5 |
| 2026-05-26 | 1%(0.3%) | 133.39 | 2.02% | 58 | 1.27% | -0.15% | 0.7 | 0.2 | 0.4% | -0.4 | Long | 55% | -1 | 2.1 |
| 2026-05-25 | 0%(0.1%) | -0.1 | -0.3 | -1 | -0.5 | |||||||||
| 2026-05-24 | 0%(0.1%) | -0.1 | -0.3 | -1 | 7.5 | |||||||||
| 2026-05-23 | 0%(0.1%) | -0.1 | -0.3 | -1 | -0.5 | |||||||||
| Wait is the preferred trading strategy with 50% chance of being right. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Market News | ||
| 1 (6) Edgewise Therapeutics To Sell Muscular Dystrophy Business & Sevasemten For Up To $2.65 Bln Edgewise Therapeutics, Inc. (EWTX), a biopharmaceutical company, Monday announced that it has agreed to sell its muscular dystrophy business and Sevasemten to Servier, an independent pharmaceutical group, for $1. (https://www.rttnews.com/) Mon. Jun 1, 2026 | ||
| 2 (-4) Jade Biosciences Stock Falls 12% Despite Reporting Positive Data From JADE101 Trial Stock of Jade Biosciences, Inc. (JBIO) is dropping about 12 percent in Monday morning trading despite the company's positive report from a Phase 1 trial evaluating JADE101 for the treatment of immunoglobulin A nephropathy. (https://www.rttnews.com/) Mon. Jun 1, 2026 | ||
| 3 (2) Why Is Jade Biosciences Stock Trading Lower On Monday? Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations. (https://www.benzinga.com/) Mon. Jun 1, 2026 | ||
| 4 (7) Why Is Replimune Stock Gaining Monday? Replimune Group (REPL) shares gain on key RP2 & RP1 oncology data presentations at ASCO. Read the clinical trial results. (https://www.benzinga.com/) Mon. Jun 1, 2026 | ||
| 5 (8) What's Going On With Summit Therapeutics Stock On Monday? Summit Therapeutics' new ivonescimab trial results showed a survival benefit in lung cancer and encouraging data in colorectal cancer. (https://www.benzinga.com/) Mon. Jun 1, 2026 | ||
| 6 (7) Edgewise to sell muscle dystrophy business to Servier for up to $2.65 billion June 1 () - Biotech firm Edgewise Therapeutics said on Monday it would sell its experimental muscular dystrophy drug and related business to France's Servier for up to $2. The French drugmaker will secure global rights to the U. (https://finance.yahoo.com/) Mon. Jun 1, 2026 | ||
About
Contact Us
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA